Richard Pazdur Eyed for FDA Chief

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded11 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2197182

Show notes

On November eleventh, a significant development in pharmaceutical regulation emerged: the U.S. Food and Drug Administration is poised to appoint oncology expert Richard Pazdur as the nations top drug regulator. This potential appointment, reported by The Washington Post, could signal a renewed focus on cancer-related drug development and approval processes. However, the FDA has not yet made an official announcement, and the formal announcement is eagerly awaited by many in the medical and pharmaceutical communities. This potential leadership change could shape the future of drug regulation in the United States for years to come.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.